Rigel Pharmaceuticals Inc (RIGL)

Cost of Revenue

$8.53M

Quarterly · Period ending: · USD

RIGL logo

RIGL Cost of Revenue

Latest reported$8.53M
RIGL Quarterly Cost of Revenue ($0.00 → $8.53M)
High-resolution chart · PNG

RIGL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
-817,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.